Impact of Bicarbonate-β-Lactam Exposures on Methicillin-Resistant

Bacterial Proteins / genetics Bacterial Typing Techniques Bicarbonates / pharmacology Drug Resistance, Multiple, Bacterial / drug effects Gene Expression Regulation, Bacterial / drug effects Humans Methicillin-Resistant Staphylococcus aureus / drug effects Microbial Sensitivity Tests RNA-Seq Regulon / drug effects beta-Lactam Resistance / drug effects beta-Lactams / pharmacology
Methicillin-resistant Staphylococcus aureus (MRSA) RNA-sequencing (RNA-seq) sodium bicarbonate (NaHCO3) β-lactam susceptibility

Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
20 10 2021
Historique:
received: 19 08 2021
revised: 06 10 2021
accepted: 08 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 15 2 2022
Statut: epublish

Résumé

Methicillin-resistant

Identifiants

DOI: 10.3390/genes12111650 PMID: 34828256 PMC: PMC8619011
pubmed: 34828256
pii: genes12111650
doi: 10.3390/genes12111650
pmc: PMC8619011
pii:
doi:

Substances chimiques

Bacterial Proteins 0
Bicarbonates 0
beta-Lactams 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI152999
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI146078
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI134637
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI121296
Pays : United States
Organisme : NIAID NIH HHS
ID : K01 AI148593
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI093749
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148342
Pays : United States

Références

Antimicrob Agents Chemother. 2019 Sep 30;:
pubmed: 31570396
J Glob Antimicrob Resist. 2014 Sep;2(3):133-140
pubmed: 27873719
J Bacteriol. 2004 Jul;186(13):4085-99
pubmed: 15205410
J Bacteriol. 1997 Nov;179(21):6756-63
pubmed: 9352927
PLoS One. 2012;7(8):e43998
pubmed: 22952845
Clin Infect Dis. 2013 Dec;57(12):1760-5
pubmed: 23985343
Antimicrob Agents Chemother. 2008 Jan;52(1):192-7
pubmed: 17984229
Antimicrob Agents Chemother. 2011 Dec;55(12):5631-9
pubmed: 21968365
Sci Rep. 2018 Feb 9;8(1):2758
pubmed: 29426873
PLoS Pathog. 2019 Apr 22;15(4):e1007713
pubmed: 31009507
P T. 2015 Apr;40(4):277-83
pubmed: 25859123
Antimicrob Agents Chemother. 2020 Apr 21;64(5):
pubmed: 32041719
Nucleic Acids Res. 2021 Jul 2;49(W1):W317-W325
pubmed: 34086934
Clin Microbiol Infect. 2010 Dec;16(12):1721-8
pubmed: 20825434
Microb Pathog. 2002 Aug;33(2):73-9
pubmed: 12202106
Nat Rev Microbiol. 2007 Jan;5(1):48-56
pubmed: 17143318
PLoS One. 2012;7(7):e41415
pubmed: 22911791
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
J Bacteriol. 2007 Oct;189(20):7316-25
pubmed: 17675373
Ann Pharmacother. 2008 May;42(5):719-21
pubmed: 18381844
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 31010857
PLoS One. 2010 Dec 02;5(12):e15177
pubmed: 21151999
Antimicrob Agents Chemother. 2021 Mar 1;:
pubmed: 33649115
Front Biosci. 2002 Aug 01;7:d1825-42
pubmed: 12133812
Mol Microbiol. 2021 Jul;116(1):41-52
pubmed: 33709487
Crit Care. 2017 Aug 14;21(1):211
pubmed: 28807042
BMC Microbiol. 2017 Nov 22;17(1):218
pubmed: 29166860
Front Microbiol. 2020 May 21;11:1028
pubmed: 32508801
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):14036-41
pubmed: 26504242
EBioMedicine. 2017 Jun;20:173-181
pubmed: 28579300
Microbiology (Reading). 2008 Aug;154(Pt 8):2265-2274
pubmed: 18667559
Can J Infect Dis Med Microbiol. 2007 Jan;18(1):27-34
pubmed: 18923684
Microbiology (Reading). 2000 Jul;146 ( Pt 7):1535-1546
pubmed: 10878118
Antimicrob Agents Chemother. 2020 Feb 21;64(3):
pubmed: 31844004
Ther Adv Endocrinol Metab. 2016 Jun;7(3):136-47
pubmed: 27293542
J Bacteriol. 2005 Mar;187(5):1815-24
pubmed: 15716453
J Glob Antimicrob Resist. 2016 Dec;7:178-186
pubmed: 27889013
mBio. 2016 Feb 09;7(1):e02070-15
pubmed: 26861022
Lancet. 2006 Sep 2;368(9538):874-85
pubmed: 16950365
Front Microbiol. 2017 Oct 04;8:1917
pubmed: 29046671
Infect Immun. 2004 Mar;72(3):1832-6
pubmed: 14977998

Auteurs

Selvi C Ersoy (SC)

The Lundquist Institute, Torrance, CA 90502, USA.
ORCID: 0000-0002-8792-2061

Blake M Hanson (BM)

Center for Infectious Diseases, School of Public Health, University of Texas Health Science Center, Houston, TX 77030, USA.
Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.

Richard A Proctor (RA)

School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706-152, USA.
ORCID: 0000-0003-3011-7958

Cesar A Arias (CA)

Center for Infectious Diseases, School of Public Health, University of Texas Health Science Center, Houston, TX 77030, USA.
Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.
Houston Methodist Hospital, Houston, TX 77030, USA.

Truc T Tran (TT)

Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX 77030, USA.
Houston Methodist Hospital, Houston, TX 77030, USA.

Henry F Chambers (HF)

UCSF School of Medicine, San Francisco, CA 94143, USA.

Arnold S Bayer (AS)

The Lundquist Institute, Torrance, CA 90502, USA.
The Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.
ORCID: 0000-0003-1968-0192

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › Impact of Bicarbonate-β-Lactam Exposures on...
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Techniques microbiologiques › Techniques bactériologiques › Techniques de typage bactérien › Impact of Bicarbonate-β-Lactam Exposures on...
questionsmedicales.fr › Produits chimiques inorganiques › Électrolytes › Ions › Anions › Carbonates › Hydrogénocarbonates › Impact of Bicarbonate-β-Lactam Exposures on...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Multirésistance aux médicaments › Multirésistance bactérienne aux médicaments › Impact of Bicarbonate-β-Lactam Exposures on...
questionsmedicales.fr › Phénomènes génétiques › Régulation de l'expression des gènes › Régulation de l'expression des gènes bactériens › Impact of Bicarbonate-β-Lactam Exposures on...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Impact of Bicarbonate-β-Lactam Exposures on...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Cocci à Gram positif › Staphylococcaceae › Staphylococcus › Staphylococcus aureus › Staphylococcus aureus résistant à la méticilline › Impact of Bicarbonate-β-Lactam Exposures on...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Impact of Bicarbonate-β-Lactam Exposures on...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ARN › RNA-Seq › Impact of Bicarbonate-β-Lactam Exposures on...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Régulon › Impact of Bicarbonate-β-Lactam Exposures on...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Résistance aux bêta-lactamines › Impact of Bicarbonate-β-Lactam Exposures on...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Impact of Bicarbonate-β-Lactam Exposures on...